DXCM
DexCom, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$88.10
−1.79%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
31.3x
EV/EBITDA
21.0x
Market Cap
$33.25B
MomentumView details →
1D Return
−1.79%
YTD Return
+32.82%
RSI (14)
53.7
ValuationView details →
P/E (Fwd)
31.3x
EV/EBITDA
21.0x
Market Cap
$33.25B
RSI (14)
53.7
MomentumView details →
1D Return
−1.79%
YTD Return
+32.82%
SummaryUpdated Jun 1, 2026
DexCom, Inc. (NASDAQ:DXCM) is a San Diego-based medical device company founded in 1999 that specializes in continuous glucose monitoring (CGM) systems for diabetes management. The company went public in 2005 and has grown to become a leading player in the diabetes technology market, serving approximately 2.8 million customers globally as of 2024. DexCom has evolved from a specialized medical device manufacturer to a comprehensive diabetes management platform, expanding its reach from traditional insulin-dependent patients to broader diabetes populations and even pre-diabetic individuals through its over-the-counter product offerings.
Similar companies
Latest newsMore news →
Dexcom and Health2Sync announced a partnership to integrate continuous glucose monitoring with digital chronic disease management for diabetes care in Australia and Singapore.12d agoAurora Investment Counsel acquired a new stake in DexCom, Inc., purchasing 34,744 shares valued at approximately $2.34 million in the most recent quarter.15d ago